DE60321129D1 - Rekombinantes herpesvirus aus truthahn und verwendung davon - Google Patents

Rekombinantes herpesvirus aus truthahn und verwendung davon

Info

Publication number
DE60321129D1
DE60321129D1 DE60321129T DE60321129T DE60321129D1 DE 60321129 D1 DE60321129 D1 DE 60321129D1 DE 60321129 T DE60321129 T DE 60321129T DE 60321129 T DE60321129 T DE 60321129T DE 60321129 D1 DE60321129 D1 DE 60321129D1
Authority
DE
Germany
Prior art keywords
turkey
recombinant herpesvirus
herpesvirus
recombinant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60321129T
Other languages
English (en)
Inventor
Kristi M Dorsey
Shuji Saitoh
Takashi Okuda
Mayumi Kubomura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zeon Corp
Original Assignee
Zeon Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeon Corp filed Critical Zeon Corp
Application granted granted Critical
Publication of DE60321129D1 publication Critical patent/DE60321129D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE60321129T 2002-01-31 2003-01-29 Rekombinantes herpesvirus aus truthahn und verwendung davon Expired - Lifetime DE60321129D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/059,152 US6866852B2 (en) 2002-01-31 2002-01-31 Recombinant herpesvirus of turkeys and use thereof
PCT/US2003/001066 WO2003064595A2 (en) 2002-01-31 2003-01-29 Recombinant herpesvirus of turkeys and use thereof

Publications (1)

Publication Number Publication Date
DE60321129D1 true DE60321129D1 (de) 2008-07-03

Family

ID=27658249

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60321129T Expired - Lifetime DE60321129D1 (de) 2002-01-31 2003-01-29 Rekombinantes herpesvirus aus truthahn und verwendung davon

Country Status (6)

Country Link
US (1) US6866852B2 (de)
EP (1) EP1467753B1 (de)
JP (1) JP4265405B2 (de)
CN (1) CN100335131C (de)
DE (1) DE60321129D1 (de)
WO (1) WO2003064595A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080241188A1 (en) * 2007-03-30 2008-10-02 Zeon Corporation Turkey herpesvirus vectored recombinant containing avian influenza genes
US20090246226A1 (en) * 2008-03-28 2009-10-01 Zeon Corporation Avian vaccines possessing a positive marker gene
PL2419132T3 (pl) 2009-04-15 2015-03-31 Ceva Sante Animale Wektory z rekombinowanego herpeswirusa ptaków i szczepionki do immunizacji wodnych gatunków ptactwa
CN101812542B (zh) * 2010-04-28 2012-05-09 国家兽用生物制品工程技术研究中心 一种快速检测细胞内火鸡疱疹病毒的方法
US9114108B2 (en) 2011-11-30 2015-08-25 Merial, Inc. Recombinant HVT vectors expressing antigens of avian pathogens and uses thereof
HRP20190525T8 (hr) 2011-11-30 2023-01-20 Boehringer Ingelheim Animal Health USA Inc. Rekombinantni vektori gallid herpesvirusa 3 (mdv serotip 2) koji eksprimiraju antigene ptičjih patogena i njihove uporabe
EP2644702A1 (de) 2012-03-30 2013-10-02 Ceva Sante Animale Multivalentes rekombinantes Vogelherpesvirus und Impfstoff zur Immunisierung von Vogelarten
EP2845904A1 (de) 2013-09-06 2015-03-11 Ceva Sante Animale Rekombinante Hühner-Herpesviren und deren Verwendungen
EP3050572A1 (de) * 2015-01-29 2016-08-03 Ceva Sante Animale Rekombinante MDV1 und Verwendungen davon
EP3263129A1 (de) 2016-06-29 2018-01-03 Ceva Sante Animale Entenenteritisvirus und verwendungen davon
CN106350475A (zh) * 2016-08-26 2017-01-25 江苏省农业科学院 一种新型火鸡疱疹病毒的细菌人工染色体、构建方法与应用
PE20191701A1 (es) 2016-12-14 2019-11-27 Boehringer Ingelheim Animal Health Usa Inc Vectores recombinantes de hvt que expresan multiples antigenos de patogenos de aves y sus usos
CN106929483B (zh) * 2017-01-19 2020-09-25 北京邦卓生物科技有限公司 表达鸡新城疫病毒f基因的重组火鸡疱疹病毒的构建及其应用
CN113226363B (zh) * 2018-12-21 2024-08-23 法国诗华大药厂 含有多个外来基因的重组禽疱疹病毒
CN110331135A (zh) * 2019-07-18 2019-10-15 扬州大学 表达基因vii型新城疫病毒融合蛋白的重组火鸡疱疹病毒候选疫苗株及制备方法
JP2022547975A (ja) 2019-09-11 2022-11-16 ゾエティス・サービシーズ・エルエルシー 鳥病原体の抗原を発現する組換えシチメンチョウヘルペスウイルスベクターおよびそれらの使用
EP4168043A1 (de) 2020-06-17 2023-04-26 Boehringer Ingelheim Vetmedica GmbH Rekombinante hvt-vektoren zur expression von influenza-hämagglutinin und immunogenen zusammensetzungen sowie herstellung und verwendungen davon
CA3195621A1 (en) 2020-10-15 2022-04-21 Motoyuki Esaki Recombinant hvt and uses thereof
CN114134124A (zh) * 2021-11-09 2022-03-04 扬州大学 一种重组火鸡疱疹病毒及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1026246B1 (de) 1997-10-03 2006-11-29 Zeon Corporation Rekombinanten des infektiösen vogel-herpesvirus und rekombinante impfstoffe, die unter dessen verwendung hergestellt wurden
JP4257472B2 (ja) * 1999-06-22 2009-04-22 日本ゼオン株式会社 プロモーター、それを含有する組み換え体及びその利用

Also Published As

Publication number Publication date
CN1774264A (zh) 2006-05-17
WO2003064595A3 (en) 2003-10-16
CN100335131C (zh) 2007-09-05
EP1467753A2 (de) 2004-10-20
JP4265405B2 (ja) 2009-05-20
US6866852B2 (en) 2005-03-15
US20030157703A1 (en) 2003-08-21
EP1467753A4 (de) 2006-08-02
JP2005515775A (ja) 2005-06-02
WO2003064595A2 (en) 2003-08-07
EP1467753B1 (de) 2008-05-21

Similar Documents

Publication Publication Date Title
DE60321129D1 (de) Rekombinantes herpesvirus aus truthahn und verwendung davon
ATE406419T1 (de) Tintenrezepturen und verwendung derselben
NO20052278L (no) Piperazinyl- og diazapanyl-benzamider og -benztioamider
DE60334292D1 (de) Ylenverbundemulsionszusammensetzung und verwendung davon
IL171501A (en) Genetically engineered cutaneous microorganisms and their use
DE60315673D1 (de) Benzotriazol-1-ylaminoacetonitril-verbindungen und deren verwendung zur schädlingsbekämpfung
ATE533508T1 (de) Cripto-blockierende antikörper und ihre verwendung
DE60208351D1 (de) Glukopyranosyloxybenzylbenzolderivate und deren medizinische verwendung
DE60230591D1 (de) Glykopyranosyloxypyrazolderivate und deren medizinische verwendung
DE60237580D1 (de) Glykopyranosyloxypyrazolderivate und deren medizinische verwendung
DE602004012969D1 (de) Phenylacetamide und ihre verwendung als glukokinase-modulatoren
SI1673460T1 (sl) Rekombinantna cepiva in njihova uporaba
DE60328087D1 (de) Aryl substituierte pyrimidine und deren verwendung
DE60144013D1 (de) Harzzusammensetzung und verwendung derselben
DE60204885D1 (de) Anschraubbarer filter und entsprechender filterkopf
DE60228120D1 (de) Sauerstoffionenleitendes keramikmaterial und verwendung davon
ATE456657T1 (de) Aromatische methyltransferasen und ihre verwendung
ATE357432T1 (de) Substituierte 2-amino-zykloalkankarboxamide und ihre verwendung als zysteinprotease-inhibitoren
DE60322052D1 (de) N-acylaminoacetonitril-derivate und ihre verwendung zur kontrolle von parasiten
DE50309696D1 (de) Induktives bauelement und verwendung des bauelements
DE50202730D1 (de) Substituierte isoindole und ihre verwendung
DE50300769D1 (de) Erdalkalialuminosilicatglas und verwendung
ATE399076T1 (de) Herstellung und verwendung von mehrkarbidmaterialien
DE50311406D1 (de) Verwendung von Formkörpern
DE60316134D1 (de) Substituierte aminoisoxazolinderivate und ihre verwendung als antidepressiva

Legal Events

Date Code Title Description
8364 No opposition during term of opposition